Elk River Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Elk River Wealth Management's PFE Position: Q2 2026 in Review
Elk River Wealth Management reduced its Pfizer (PFE) stake by 2.1% in Q2 2026, selling an estimated $9.63K and leaving 17,404 shares worth $419K. The position accounts for 0.07% of the portfolio, ranked #84.
Elk River Wealth Management first reported a position in PFE in Q4 2020 and has held it in 23 quarters since. The position peaked at $1.73M in Q4 2021. 2,836 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Elk River Wealth Management held 17,404 shares of Pfizer worth $419K as of Q2 2026.
- Elk River Wealth Management sold 368 Pfizer shares in Q2 2026, an estimated $9.63K.
- Pfizer made up 0.07% of Elk River Wealth Management's portfolio in Q2 2026, its #84 holding.
- Elk River Wealth Management first reported a position in Pfizer in Q4 2020 and has held it in 23 quarters since.
- Elk River Wealth Management's Pfizer position peaked at $1.73M in Q4 2021.
- 2,836 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Elk River Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.